Project Grant R01DE034776

Award Date 5/1/25
Completion Date 4/30/30
Dollars Obligated $629K
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research Program (CFDA 93.121) is focused on investigating the role of cellular senescence in Sjögren's syndrome, a chronic autoimmune disease that impairs salivary gland function and leads to dry mouth. The $248,750 award to the ADA Forsyth Institute, Inc. in Cambridge, Massachusetts will support research to determine the impact of cellular senescence on...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $226,500 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to The Medical University of South Carolina. The goal of this 2-year research project is to define how oral pathogens affect aging-associated immune responses and determine if inhibition of the CD38 enzyme can alleviate inflammatory bone loss and aging-associated immune responses induced by oral bacteria. The researchers will...
This Project Grant award of $115,992 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), supports the development of human induced pluripotent stem cell (iPSC)-derived salivary gland organoids with secretory function and well-defined architecture. The key objectives are to: 1) Utilize engineered viscoelastic hydrogels to optimize the generation and differentiation of salivary gland epithelial progenitor...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research (CFDA 93.121) program will provide $248,999 to investigate the role of tuft cells in salivary gland immunity. The key objectives are to: Explore the distribution and function of tuft cells in salivary gland epithelium using advanced microscopy and in vivo experiments. Determine the chemosensory components of tuft cells in the salivary gland using...
This $473,632 federal Project Grant, awarded by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), will fund research to understand the role of megakaryocytes (large bone marrow cells) in oral mucosal immunity during oropharyngeal candidiasis, a common fungal infection affecting immunocompromised patients. The research aims to elucidate how interleukin-17 receptor (IL-17R) signaling in megakaryocytes...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $491,193 Project Grant under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121) to the University of California, San Diego (UCSD) to develop advanced artificial mucin substitutes that can replicate the essential protective functions of natural salivary mucins. The key objectives are to: (1) craft artificial mucins that match the physicochemical properties of natural salivary mucins, (2)...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $109,548 Project Grant under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121) to the Regents of the University of Michigan. The grant supports a research project focused on investigating the role of myeloid cells in the evolution of precancerous oral lesions to head and neck squamous cell carcinoma (HNSCC). The project aims to develop a preclinical mouse model to study the transition from...
This Project Grant award, provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research to investigate the role of the lysyl oxidase propeptide (LOX-PP) in regulating macrophage phenotypes and their impact on oral squamous cell carcinoma (OSCC) progression. The $612,048 award to the ADA Forsyth Institute, Inc. will fund investigations to determine how wildtype LOX-PP and a polymorphic variant...
This federal Project Grant award, identified as R03DE033467, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The $339,000.00 award supports research conducted by New York University School of Medicine to investigate the role of autocrine cholinergic signaling in maintaining memory T cell responses in oral squamous cell carcinoma. The research project will take place from August 1, 2024, to...
This Project Grant award for $400,387 was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research Federal Grant Program (CFDA 93.121) to the University of Wisconsin System on August 9, 2024. The award will support research to define the pathogenesis of Sjögren's disease by examining the role of salivary gland mesenchymal stromal cells (SG-MSCs) in different disease endotypes. The research aims to determine the signaling...

The National Institute of Dental and Craniofacial Research (NIDCR) awarded a 5-year, $628,965 Project Grant (CFDA 93.121 - Oral Diseases and Disorders Research) to the Icahn School of Medicine at Mount Sinai to study how immune cells, specifically macrophages, regulate the development and differentiation of salivary gland cells. The research aims to elucidate the cellular and molecular mechanisms by which macrophages govern salivary gland progenitor dynamics and epithelial cell patterning, with the goal of identifying novel targets for therapeutic strategies to repair, regenerate, and restore salivary gland function. This work leverages the institution's expertise in salivary gland biology, discrete progenitor cell dynamics, and immune-epithelial cell interactions, and will utilize genetic mouse models and transcriptomic approaches to determine how macrophage-derived signals regulate multiple aspects of salivary gland morphogenesis.

Generated 5/13/25, 4:13 AM